Jabra Enhance Select 700 vs Lexie B3

The Jabra Enhance Select 700 is a premium-priced OTC hearing aid available at $1,795, earning a B grade with a SoundScore of 3.8/5 in our lab testing. This behind-the-ear device ranks #26 of 65 OTC hearing aids tested, placing it in the top 38% of the category. In our testing, the Enhance Select 700 showed notable strengths in comfort-related metrics. Own-voice comfort scored a solid 3.7/5, measuring 1.19 points above the category average—a meaningful advantage for wearers sensitive to the sound of their own voice. Feedback handling was excellent at 5.0/5, well above the 4.54 category average, indicating reliable stability during typical wear. Speech performance presented a mixed picture. Speech in quiet scored a solid 3.1/5, sitting 0.27 points above average. However, speech in noise was a weakness at 1.0/5, falling 0.48 points below the category average—an important consideration if challenging listening environments are a priority. Music streaming scored 2.5/5, which is above the category average by 0.58 points but only mixed in absolute terms. At this price point, several alternatives delivered stronger overall performance in our testing, including the Lucid Tala (4.61/5) and Audicus Omni 2 (4.59/5). The Jabra Enhance Select 300 and Lucid Engage also achieved higher scores at lower prices. The Enhance Select 700 may suit those prioritizing own-voice comfort and feedback stability over speech-in-noise performance, but shoppers should weigh these trade-offs carefully given the premium pricing.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.